VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the "Company" or "Stallion") (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce that, further to its news releases dated April 1, 2025 and April 8, 2025, it has closed a non-brokered private placement for aggregate gross proceeds of CDN$1,450,000 (the "Offering"). The offered securities described in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as ...

Core Viewpoint - Talisker Resources Ltd. has increased the maximum gross proceeds of its private placement from C$6,500,000 to C$7,000,000 due to strong investor demand [1] Group 1: Offering Details - The revised Offering consists of the sale of up to 14,000,000 units at a price of $0.50 per Unit [1] - Each Unit includes one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one common share at an exercise price of $0.75 for 36 months post-Closing Date [2] - Red Cloud Securities Inc. has the option to sell an additional 2,000,000 Units for up to an additional C$1,000,000 in gross proceeds [3] Group 2: Regulatory Compliance - Up to 11,320,000 Units may be sold under the Offering in Canadian Selling Jurisdictions, excluding Québec, under the listed issuer financing exemption [4] - Non-LIFE Units may be issued to accredited investors in Canada and purchasers outside Canada, including the U.S., under certain exemptions [5] Group 3: Use of Proceeds - The net proceeds from the Offering will be used for advancing the Bralorne Gold Project in British Columbia, general corporate purposes, and working capital [8] Group 4: Closing Information - The Offering is scheduled to close on or about April 29, 2025, subject to regulatory approvals [7]

Core Points - Safe & Green Holdings Corp. has announced a Private Placement expected to generate approximately $8.0 million in gross proceeds [1][3] - The offering includes 20,408,160 Common Units, which consist of shares of Common Stock and two types of Warrants with specific exercise prices [2] - The transaction is anticipated to close on or about April 14, 2025, subject to customary closing conditions [3] Offering Details - Each Common Unit consists of one share of Common Stock or one Pre-Funded Warrant, along with Series A and Series B Registered Common Warrants [2] - The public offering price per Common Unit is set at $0.392, while the Pre-Funded Unit price is $0.3919 [2] - The Series A Warrants have an initial exercise price of $0.784 and expire in 60 months, while Series B Warrants have an exercise price of $0.98 and expire in 30 months [2] Use of Proceeds - The net proceeds from the offering will be utilized for working capital, general corporate purposes, and equipment for expansion [3] Legal and Advisory Information - D. Boral Capital is acting as the Exclusive Placement Agent, and legal counsel is provided by Sichenzia Ross Ference Carmel LLP and Lucosky Brookman LLP [4] - The securities are being sold in a private placement and have not been registered under the Securities Act, limiting their resale [4] Company Overview - Safe & Green Holdings Corp. specializes in the development, design, and fabrication of modular structures, focusing on safe and green solutions across various industries [6] - The company supports developers, architects, builders, and owners in achieving faster execution and greener construction [6]

Summary of Key Points Core Viewpoint - Titan Pharmaceuticals, Inc. has completed a private placement of Series B Convertible Preferred Stock with Blue Harbour Asset Management for a total of $1,000,000, with a conversion price set at $3.00 per share [1]. Group 1: Private Placement Details - The private placement involved the sale of 100,000 shares of Preferred Stock to Blue Harbour for an aggregate purchase price of $1,000,000 [1]. - The shares sold in this transaction are not part of a public offering and have not been registered under the Securities Act of 1933, relying on Regulation S [3]. - Titan has entered into a registration rights agreement with Blue Harbour, which outlines certain registration rights upon the occurrence of specified events [3]. Group 2: Ownership Conversion Blocker - The Certificate of Designations for the Preferred Stock includes a beneficial ownership conversion "blocker" that limits Blue Harbour's ability to acquire more than 19.99% of the Company's outstanding common stock without shareholder approval [2]. Group 3: Financial Advisory - ARC Group Ltd. acted as the sole financial advisor to Titan Pharmaceuticals during this private placement [4].

Core Viewpoint - Polyrizon Ltd. has successfully closed a private placement raising approximately $17.0 million through the sale of Ordinary Shares and/or pre-funded and investor warrants at a price of $0.48 per Ordinary Unit [1][3]. Group 1: Offering Details - The offering included the sale of 35,416,667 Ordinary Units, each comprising one Ordinary Share or Pre-Funded Warrant and one Series A Warrant to purchase one Ordinary Share [2]. - The initial exercise price for each Series A Warrant is set at $1.20 per Ordinary Share, with a term of 30 months, and is subject to shareholder approval [2]. - The Pre-Funded Warrants can be exercised at any time following shareholder approval [2]. Group 2: Use of Proceeds - The net proceeds from the offering, along with existing cash, are intended for general corporate purposes and working capital [3]. Group 3: Company Overview - Polyrizon is a development-stage biotech company focused on innovative intranasal hydrogels that create a barrier against viruses and allergens in the nasal cavity [6]. - The company's proprietary technology, Capture and Contain TM, aims to function as a "biological mask" and is being further developed for drug delivery [6]. - Polyrizon is also working on an earlier-stage technology, Trap and Target ™, for nasal delivery of active pharmaceutical ingredients [6].

Pelangio Exploration Announces Closing of Private Placement for Gross Proceeds of $1,000,000 March 29, 2025 1:00 PM EDT | Source: Pelangio Exploration Inc. Toronto, Ontario--(Newsfile Corp. - March 29, 2025) - Pelangio Exploration Inc. (TSXV: PX) (OTC Pink: PGXPF) ("Pelangio" or the "Company") is pleased to announce that it has closed a non-brokered private placement of 25,000,000 units (the "Units") of the Company at a price of $0.04 per Unit for gross proceeds of $1,000,000 (the "Private Placement"). Each ...

Core Viewpoint - SINTX Technologies, Inc. has successfully completed a private placement of common stock and warrants, raising approximately $5 million for working capital purposes [1][2]. Group 1: Private Placement Details - The company issued and sold 1,449,287 shares of common stock at a price of $3.45 per share, along with unregistered warrants to purchase an equal number of shares at an exercise price of $3.32 [1][2]. - The offering closed on February 25, 2025, and was facilitated by H.C. Wainwright & Co. as the exclusive placement agent [2]. Group 2: Securities Regulation - The securities were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933 and Regulation D, and have not been registered under the Act or applicable state securities laws [3]. - The company has agreed to file registration statements with the SEC for the resale of the shares and those issuable upon exercise of the warrants [3]. Group 3: Company Overview - SINTX Technologies is based in Salt Lake City, Utah, and specializes in advanced ceramics for medical applications, particularly silicon nitride, which has been implanted in humans since 2008 [5]. - The company has pursued strategic acquisitions and alliances to expand into new markets [5].

As filed with the U.S. Securities and Exchange Commission on December 20, 2024. Registration No. 333-281806 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Ribbon Acquisition Corp (Exact name of registrant as specified in its constitutional documents) Cayman Islands 6770 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. ...

As filed with the U.S. Securities and Exchange Commission on December 16, 2024. Registration No. 333-281144 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ______________________ Plum Acquisition Corp. IV (Exact Name of Registrant as Specified in its Charter) ______________________ | Cayman Islands | 6770 | 98-1795710 | | --- | --- | --- | | (State or Other Jurisdiction of | (Primary Standard Industri ...

As filed with the U.S. Securities and Exchange Commission on December 16, 2024. Registration No. 333-281144 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ______________________ Plum Acquisition Corp. IV (Exact Name of Registrant as Specified in its Charter) ______________________ | Cayman Islands | 6770 | 98-1795710 | | --- | --- | --- | | (State or Other Jurisdiction of | (Primary Standard Industri ...